Pharma Research
Ono Pharma Reports Positive Phase 2 Signals for ONO-2808 in Multiple System Atrophy
Efficacy signals were observed in an interim analysis of a Phase 2 clinical trial for ONO-2808, a S1P5 receptor agonist Phase 2 clinical trial was con...
October 13, 2025 | News
MOLCURE and Boehringer Ingelheim Forge AI-Powered Alliance to Accelerate Antibody Drug Discovery
MOLCURE Inc. announced that it has entered into a multi-year strategic research agreement with Boehringer Ingelheim for the discovery of innovative an...
October 08, 2025 | News
Asia-Pacific Takes the Lead in Global Biopharma Resilience: Cytiva’s 2025 Index Highlights Regional Rise Amid Global Slowdown
The 2025 Global Biopharma Index released by Cytiva, a Danaher company, reveals that while the global biopharma ecosystem has experienced a modest decline i...
October 08, 2025 | Analysis
Wasatch BioLabs Expands Long-Read Sequencing Portfolio with Oxford Nanopore Research Assays
Wasatch BioLabs (WBL), a Renew Biotechnologies subsidiary, and the largest U.S. sequencing service provider dedicated exclusively to long-read se...
October 07, 2025 | News
Australia’s Monash University Launches Boston Hub to Accelerate Global Biotech Partnerships
Top‑50 global university deepens its North America and Europe collaborations to fast‑track drug discovery and health innovation. Monash University, Au...
October 06, 2025 | News
Japan’s Daiichi Sankyo Expands Global R&D Footprint with New Research Institute in San Diego
Daiichi Sankyo (TSE: 4568) has established Daiichi Sankyo Research Institute in San Diego, representing the third research institute established outside of...
October 06, 2025 | News
HKUST Uncovers Genetic Variant Driving Alzheimer’s Risk Among Ethnic Chinese
A landmark study conducted by The Hong Kong University of Science and Technology (HKUST) has demonstrated that a genetic variant, TREM2 ...
October 06, 2025 | News
Japan Grants National Reimbursement for MedHub-AI AutocathFFR Marking a Breakthrough in AI-Driven Coronary Physiology
MedHub-AI announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved national reimbursement for the company's Autoca...
October 06, 2025 | News
Teijin and Cell Therapies Forge a Cross-Border Alliance to Accelerate Cell and Gene Therapy Access Between Japan and Australia
As the cell and gene therapy (CGT) sector moves from scientific promise to large-scale reality, collaboration between nations with strong translational and...
October 06, 2025 | News | By arcilla.fran@biopharmaapac.com
Thermo Fisher’s PPD™ Clinical Research Joins AstraZeneca BioVentureHub for R&D Partnership in Sweden
The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, announced a new research and development ...
October 02, 2025 | News
PromoCell Enters GMP Market with Custom Cell Culture Media Services for Clinical Applications
PromoCell GmbH, a leading global manufacturer of primary human cells and specialized cell culture media for biomedical research, announces its entry into t...
October 01, 2025 | News
Lunit and CellCarta Form Global Partnership to Advance AI-Powered Pathology in Clinical Trials
Lunit , a leading provider of AI for cancer diagnostics and biomarkers for oncology therapeutics, announced a strategic partnership with CellCarta, a globa...
September 25, 2025 | News
Merck and Siemens Forge Digital Alliance to Transform Drug Discovery and Manufacturing
Memorandum of Understanding signed to deliver end-to-end digital workflows from drug discovery to manufacturing Combines technology from the Siemens...
September 24, 2025 | News
SOPHiA GENETICS Expands Collaboration with AstraZeneca to Advance AI-Powered Genomic Testing in Breast and Prostate Cancer
SOPHiA GENETICS an AI technology company transforming precision medicine announced an expansion of its collaboration with AstraZeneca (LSE/STO/Nasdaq:...
September 23, 2025 | News
Most Read
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
